While surfactant protein-B (SP-B), produced by AT2 cells, is known to inhibit hydrolysis of surfactant phospholipids by sPLA2, AT2 hyperplasia is the key pathological feature of pulmonary fibrosis [69]. This evidence concerns the gene SFTPB and pulmonary fibrosis.